Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2078 USD | +10.53% | +12.20% | -16.78% |
05-15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.78% | 4.87M | |
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+1.48% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Obalon Therapeutics, Inc. Announces Resignation of David Moatazedi as Member of the Board, the Compensation Committee, and the Audit Committee